2 studies found for:    181845 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer
Conditions: Kidney Cancer;   Lung Carcinoma;   Sarcomas;   Breast Cancer;   Ovarian Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: aldesleukin;   Biological: recombinant interleukin-12
2 Completed Ultra Low Dose Interleukin-2 in Healthy Volunteers
Condition: Hematologic Diseases
Interventions: Drug: Interleukin-2 (100,000 international units);   Drug: Interleukin-2 (200,000 international units)

Indicates status has not been verified in more than two years